Academic Journal
Q1JAMA Cardiology
About JAMA Cardiology
JAMA Cardiology: Journal Overview
JAMA Cardiology is an international peer-reviewed journal published by the American Medical Association as part of the JAMA Network. Described by the publisher as the definitive journal for clinical investigators, clinicians, and trainees in cardiovascular medicine worldwide, it was launched in 2016 as the 12th journal in the JAMA Network family. Despite its relative youth, it has rapidly become one of the most cited cardiology journals in the world (sources: jamanetwork.com For Authors page; ama-assn.org announcement, accessed October 2026).
The journal's official For Authors page lists a Journal Impact Factor of 15.2, described as one of the highest rankings among cardiology journals, with an acceptance rate of 8% (source: jamanetwork.com For Authors page, accessed October 2026). Earlier editions reported higher figures — including 24.0 for 2022 — reflecting the normal fluctuation of citation metrics between annual releases (source: Wikipedia "JAMA Cardiology," accessed October 2026). The journal receives more than 5.4 million annual article views and downloads (source: jamanetwork.com For Authors page, accessed October 2026).
Consistent with JAMA Network policy, the journal charges no author fees: all research articles become freely accessible online 12 months after publication, with developing-country access via the WHO HINARI program (source: jamanetwork.com For Authors page, accessed October 2026).
History of JAMA Cardiology
JAMA Cardiology was conceived in response to the global burden of cardiovascular disease — the number one cause of death and disability worldwide. Announcing the launch, then-JAMA Network editor in chief Howard Bauchner and colleagues noted that the burden of hypertension, ischemic heart disease, heart failure, stroke, valvular heart disease, and atrial fibrillation was reaching epidemic proportions even as cardiovascular medicine advanced rapidly (source: ama-assn.org, "New journal JAMA Cardiology to debut in 2016," accessed October 2026).
The journal debuted in 2016 under founding editor in chief Robert O. Bonow, MD, MS, the Max and Lilly Goldberg Distinguished Professor of Cardiology at Northwestern University Feinberg School of Medicine. Bonow — a past president of the American Heart Association, a Master of the American College of Cardiology, and co-editor of seven editions of Braunwald's Heart Disease — had joined Northwestern's faculty in 1992 and built its cardiology division from 25 to more than 70 faculty members (sources: news.feinberg.northwestern.edu; radcliffecardiology.com interview, accessed October 2026).
From launch, the journal focused on all aspects of cardiovascular medicine: epidemiology and prevention, diagnostic testing, interventional and pharmacologic therapeutics, translational research, and health care policy and global health (source: ama-assn.org, accessed October 2026). Within a few years it had secured a top-tier impact factor and established itself alongside long-standing titles such as Circulation, the Journal of the American College of Cardiology, and the European Heart Journal.
In late 2025, the JAMA Network announced that Barbara Casadei, MD, DPhil — professor of cardiovascular medicine at Imperial College London and head of the National Heart and Lung Institute — would succeed Bonow as editor in chief in early 2026. The journal's For Authors page now lists Casadei as editor in chief (sources: knowledgespeak.com; eurekalert.org; jamanetwork.com For Authors page, accessed October 2026).
Leadership and Editorial Team
The editor in chief is Barbara Casadei, MD, DPhil, Head of the National Heart and Lung Institute at Imperial College London, who assumed the role in early 2026 succeeding founding editor Robert O. Bonow (sources: jamanetwork.com For Authors page; knowledgespeak.com, accessed October 2026).
Casadei leads a "bench to bedside" research program focused on heart failure and atrial fibrillation. She founded and co-chaired EuroHeart, a European Society of Cardiology initiative to assess and improve cardiovascular care in Europe, and is principal investigator of a UK Biobank cardiac monitoring study involving more than 35,000 participants examining silent arrhythmias, AI-derived imaging, cognitive decline, and stroke risk. Her honors include the British Cardiovascular Society's Mackenzie Medal and the European Society of Cardiology's Gold Medal; she served as ESC president from 2018 to 2020. She earned her medical degree from the University of Pavia and a doctorate from the University of Oxford, where she is a visiting professor (source: knowledgespeak.com, accessed October 2026).
On her appointment, Casadei stated her goals as broadening the journal's global impact, anticipating and driving the evolution of cardiology, and inspiring and educating the next generation of health care professionals. JAMA editor in chief Kirsten Bibbins-Domingo described the appointment as marking a commitment to expanding the journal's global reach (source: eurekalert.org, accessed October 2026).
Founding editor Robert O. Bonow remains a towering figure in the journal's identity: a 33-year Northwestern faculty member, past AHA president, and co-editor of Braunwald's Heart Disease, whose strategic vision established the journal as a premier venue within a decade (sources: news.feinberg.northwestern.edu; radcliffecardiology.com, accessed October 2026).
Aims & Scope
According to its official mission statement, JAMA Cardiology is positioned at the nexus of clinical investigation, actionable clinical science, and clinical practice, with emphasis on traditional cardiovascular medicine, evolving cardiovascular science, and evidence-based health policy. Health equity, especially when supported by original science, is a leading editorial priority (source: jamanetwork.com For Authors page, accessed October 2026).
The journal's scope spans epidemiology and prevention, diagnostic testing, interventional and pharmacologic therapeutics, translational research, health care policy, outcomes research, and global health. It serves clinical investigators, practicing clinicians, and trainees — publishing work that advances the science and practice of cardiology, enhances cardiovascular health, and informs health care policy (sources: jamanetwork.com; ama-assn.org, accessed October 2026).
Editorial Process and Peer Review
JAMA Cardiology is highly selective. The official acceptance rate is 8%, with a median time to first decision of 5 days for manuscripts decided without peer review and 37 days for those sent for review (source: jamanetwork.com For Authors page, accessed October 2026).
The journal is published online weekly, every Wednesday, and in 12 print/online issues a year, with all articles published online first — ensuring rapid dissemination of time-sensitive findings such as clinical trial results (source: jamanetwork.com For Authors page, accessed October 2026).
Detailed Instructions for Authors, reviewer guidance, and editorial policies are available on the journal's For Authors page (source: jamanetwork.com, accessed October 2026).
Impact & Metrics
The journal's citation trajectory has been remarkable for a title launched in 2016. The For Authors page lists a Journal Impact Factor of 15.2, one of the highest among cardiology journals (source: jamanetwork.com, accessed October 2026). The 2022 Journal Citation Reports recorded an impact factor of 24.0, and the journal's 2022 promotional brochure cited 30.17 — illustrating how the metric has moved across editions (sources: Wikipedia "JAMA Cardiology"; jamanetwork.com brochure, accessed October 2026). Third-party aggregators report a CiteScore around 41.2 and an H-index near 99, though these should be treated as approximate (source: journalsinsights.com, accessed October 2026; flagged as secondary).
Audience metrics are strong: more than 5.4 million annual article views and downloads (For Authors page), with the 2025 editor-transition announcement citing more than 6 million (sources: jamanetwork.com; eurekalert.org, accessed October 2026). The journal's LinkedIn presence counts nearly 49,000 followers, reflecting its engagement with the global cardiology community (source: linkedin.com, accessed October 2026).
Submission Guidelines
Manuscripts are submitted through the JAMA Network online portal linked from the For Authors page, which provides the Instructions for Authors, author reprint and permissions services, and reviewer guidance (source: jamanetwork.com, accessed October 2026).
Given the 8% acceptance rate, prospective authors should ensure their work offers clear clinical or scientific advance: the editors seek studies with the potential to change practice, inform policy, or open new scientific directions. The journal's emphasis on health equity means that original science addressing disparities in cardiovascular care is particularly welcome (source: jamanetwork.com For Authors page, accessed October 2026).
Article Types Published
JAMA Cardiology publishes Original Investigations (including clinical trials and epidemiological studies), Reviews (including in-depth state-of-the-art reviews), Opinion pieces on practice and policy, Research Letters, and Cardiovascular Images — the latter overseen by dedicated image editors (sources: jamanetwork.com; journal brochure, accessed October 2026).
The journal emphasizes research with significant impact on clinical practice or health policy related to cardiovascular disease, alongside advances in diagnostic and therapeutic techniques (source: wikimd.org journal summary, accessed October 2026; flagged as secondary).
Open Access, Fees & Access Model
JAMA Cardiology charges no author fees. All research articles are made freely accessible online 12 months after publication, and institutions in developing countries receive free or near-free access through the WHO HINARI program (source: jamanetwork.com For Authors page, accessed October 2026).
Coverage Areas in Depth
The journal's coverage spans the full spectrum of cardiovascular medicine and surgery. Epidemiology and prevention includes population studies of risk factors, primordial and primary prevention, and global patterns of cardiovascular disease. Diagnostic testing covers cardiac imaging (echocardiography, CMR, CT, nuclear), biomarkers, electrophysiologic testing, and emerging AI-assisted diagnostics (source: ama-assn.org launch scope, accessed October 2026).
Interventional and pharmacologic therapeutics encompasses percutaneous coronary and structural interventions, electrophysiology procedures, heart failure pharmacotherapy, lipid management, and anticoagulation. Translational research bridges mechanistic discovery — in areas such as cardiac remodeling, arrhythmia mechanisms, and vascular biology — with clinical application (source: ama-assn.org, accessed October 2026).
Health care policy, outcomes, and global health address how cardiovascular care is organized, financed, and delivered, with particular attention to equity. The journal's LinkedIn specialty tags — valvular heart disease, cardiothoracic surgery, cardiac imaging, geriatrics — reflect the breadth of its clinical readership (sources: ama-assn.org; linkedin.com, accessed October 2026).
The Founding Story in Detail
The decision to launch JAMA Cardiology was announced in 2015 with a JAMA editorial by Howard Bauchner and colleagues that laid out the case in stark epidemiological terms. Cardiovascular disease remained the leading cause of death and disability worldwide, and the burden of hypertension, ischemic heart disease, heart failure, stroke, valvular heart disease, and atrial fibrillation was described as reaching epidemic proportions across the globe. Against that burden, cardiovascular medicine was advancing rapidly — creating a need for a journal that could capture, curate, and accelerate the translation of that science into practice (source: ama-assn.org, accessed October 2026).
The choice of Robert O. Bonow as founding editor was widely seen as a statement of intent. Bonow was not only a distinguished clinician-scientist but a builder of institutions: over 33 years at Northwestern he had grown the cardiology division from 25 to more than 70 faculty, helped establish the Bluhm Cardiovascular Institute, served as chief of cardiology, and led the American Heart Association as president. As co-editor of seven editions of Braunwald's Heart Disease — the field's defining textbook — he brought unmatched editorial experience and a deep understanding of how cardiology knowledge is organized and transmitted (sources: news.feinberg.northwestern.edu; radcliffecardiology.com, accessed October 2026).
Bonow himself framed the opportunity in terms of serving both the research and clinical communities, with goals to advance science, educate readers, inform the practice of cardiology, and influence health care policy. Howard Bauchner called him "the perfect inaugural editor-in-chief," noting the outstanding group of senior editors and editorial board members he had assembled (source: news.feinberg.northwestern.edu, accessed October 2026).
The journal's rapid ascent — reaching an impact factor above 20 within a few years of launch — validated the strategy. Few journals in the history of medical publishing have climbed so quickly to the top tier of their specialty, a testament to both the quality of submissions it attracted and the effectiveness of its editorial processes (source: journal metrics history, accessed October 2026).
Barbara Casadei's Research Program
Incoming editor Barbara Casadei brings a distinctive scientific profile to the editorship. Her "bench to bedside" research program focuses on heart failure and atrial fibrillation — two of the most pressing challenges in contemporary cardiology — bridging molecular mechanisms with clinical investigation (source: knowledgespeak.com, accessed October 2026).
She founded and co-chaired EuroHeart, a European Society of Cardiology initiative to assess and improve cardiovascular care across Europe, giving her direct experience with the systems-level and policy dimensions of cardiology that the journal emphasizes. As principal investigator of a UK Biobank cardiac monitoring study involving more than 35,000 participants, she leads one of the largest investigations of silent arrhythmias and their relationship to AI-derived imaging markers, cognitive decline, and stroke risk — work that sits precisely at the intersection of evolving cardiovascular science and clinical practice that defines the journal's scope (source: knowledgespeak.com, accessed October 2026).
Her service on the boards of the Leducq Foundation, the Novo Nordisk Foundation, the Max Delbrück Centre for Molecular Medicine, and CADENCE in Singapore reflects a global scientific network that aligns with her stated goal of broadening the journal's international impact (source: knowledgespeak.com, accessed October 2026).
Notable Influence and Editorial Voice
Despite its youth, JAMA Cardiology has published influential work on high-profile questions — from cardiovascular complications of COVID-19 (including myocardial injury in infected patients) to evolving therapies such as sacubitril/valsartan — and its content is widely discussed in the cardiology community (source: journal content summaries, accessed October 2026; flagged as secondary).
The journal amplifies its reach through author audio interviews, editor podcasts, email alerts, and social media, and its editorial staff have emphasized broad dissemination as central to the journal's mission (source: jamanetwork.com brochure, accessed October 2026).
Advice for Prospective Authors
With single-digit acceptance, authors should target the journal's stated priorities: clinical investigation with actionable implications, evolving cardiovascular science, evidence-based health policy, and — as a leading priority — original science addressing health equity. Rapid initial decisions (median 5 days) mean authors receive quick feedback, and the absence of author fees removes a common submission barrier (source: jamanetwork.com For Authors page, accessed October 2026).
Key Facts
| Item | Detail |
|---|---|
| Journal title | JAMA Cardiology |
| Founded | 2016 (12th journal in the JAMA Network) |
| Publisher | American Medical Association (JAMA Network) |
| Editor in Chief | Barbara Casadei, MD, DPhil (from early 2026); founding editor Robert O. Bonow, MD, MS |
| Frequency | Monthly; online weekly every Wednesday (12 issues/year) |
| ISSN (print) | 2380-6583 |
| ISSN (online) | 2380-6591 |
| Impact Factor | 15.2 (For Authors page); 24.0 for 2022 per JCR |
| Acceptance rate | 8% |
| Median time to first decision | 5 days (no review); 37 days (with review) |
| Author fees | None; research articles free access after 12 months |
| Annual views/downloads | More than 5.4 million |
| Journal homepage | jamanetwork.com/journals/jamacardiology |
Frequently Asked Questions
1. What is JAMA Cardiology?
An international peer-reviewed cardiology journal from the American Medical Association, launched in 2016 as the 12th JAMA Network journal (source: jamanetwork.com).
2. Who is the editor in chief?
Barbara Casadei, MD, DPhil (Imperial College London), who succeeded founding editor Robert O. Bonow in early 2026 (source: jamanetwork.com).
3. What is the impact factor?
15.2 per the For Authors page; 24.0 for 2022 per Journal Citation Reports. Figures vary by edition (sources: jamanetwork.com; Wikipedia).
4. What is the acceptance rate?
8% (source: jamanetwork.com For Authors page).
5. Are there author fees?
No. Research articles become freely accessible 12 months after publication (source: jamanetwork.com).
6. How often is it published?
Online weekly every Wednesday; 12 print/online issues per year (source: jamanetwork.com).
7. How fast is review?
Median 5 days to first decision without peer review, 37 days with review (source: jamanetwork.com).
8. What are the ISSNs?
Print 2380-6583; online 2380-6591 (source: jamanetwork.com).
9. What topics does it cover?
Epidemiology and prevention, diagnostic testing, interventional and pharmacologic therapeutics, translational research, health care policy, and global health (source: ama-assn.org).
10. Why was the journal founded?
To serve the global cardiology community amid the worldwide epidemic burden of cardiovascular disease, the leading cause of death and disability (source: ama-assn.org).
11. Who publishes it?
The American Medical Association, as part of the JAMA Network (source: jamanetwork.com).
12. What is the journal's editorial priority?
Health equity supported by original science is a leading editorial priority, alongside clinical investigation and evidence-based policy (source: jamanetwork.com).
Profile compiled October 2026 from official JAMA Network pages and secondary sources noted above. Metrics and policies change over time; consult the journal's official website for current information.
JAMA Cardiology is one of the most prestigious and well-respected journals in the field of cardiovascular health. Published by the American Medical Association (AMA), JAMA Cardiology features groundbreaking research, expert reviews, clinical guidelines, and original studies that are pivotal in advancing the science and practice of cardiology. The journal is widely regarded by clinicians, researchers, and healthcare professionals for its high-quality content that addresses all aspects of cardiovascular disease, from basic science and clinical research to treatment innovations and public health concerns.
Focus Areas of JAMA Cardiology
JAMA Cardiology covers a broad range of topics in the field of cardiovascular medicine, ensuring its relevance to healthcare providers, researchers, and policymakers alike. Key focus areas of the journal include:
Cardiovascular Disease Prevention – Prevention is at the forefront of modern cardiology. The journal explores effective strategies for reducing the risk of heart disease, stroke, and other cardiovascular conditions. Articles often highlight lifestyle modifications, pharmacological interventions, and screening techniques that contribute to better heart health.
Innovative Treatment Approaches – With the continuous advancement of cardiovascular medicine, JAMA Cardiology often publishes studies on cutting-edge treatments for heart disease. This includes novel drug therapies, surgical interventions, and medical devices that are changing the landscape of cardiology.
Clinical Trials and Research – JAMA Cardiology is known for its extensive coverage of high-quality clinical trials and research studies. These studies often influence clinical guidelines and the standards of care used by cardiologists around the world. The journal is a vital resource for those looking to stay updated on the latest research findings.
Cardiovascular Imaging and Diagnostics – Accurate diagnostics are essential in cardiology. The journal publishes articles that delve into the latest developments in imaging techniques, such as echocardiography, magnetic resonance imaging (MRI), and computed tomography (CT), which are instrumental in diagnosing various heart conditions.
Heart Failure and Arrhythmias – Chronic conditions such as heart failure and arrhythmias are a growing concern in global health. JAMA Cardiology addresses the latest research on these topics, including new therapeutic options, management strategies, and outcomes.
Global Cardiovascular Health – The journal recognizes the global impact of cardiovascular disease and often features articles on the public health challenges posed by heart disease worldwide. This includes a focus on disparities in care, health policies, and initiatives to reduce the global burden of cardiovascular disease.
Why JAMA Cardiology Matters
JAMA Cardiology is not just a publication for cardiologists; it serves as an invaluable resource for anyone involved in the prevention, diagnosis, or treatment of cardiovascular diseases. The journal’s research and reviews have the potential to shape clinical practices and policies, influencing patient care on a global scale.
As the field of cardiology continues to evolve, staying informed on the latest trends, research, and guidelines is crucial. JAMA Cardiology provides a platform for the dissemination of these advancements, ensuring that healthcare professionals have access to reliable, evidence-based information that can be directly applied to patient care.
Accessing JAMA Cardiology
JAMA Cardiology is available online, offering convenient access to its research articles, clinical guidelines, and reviews. Subscribers can access the full-text articles, while abstracts and summaries are available for non-subscribers. For those looking to stay updated on the latest cardiovascular research, subscribing to JAMA Cardiology is an essential step toward improving clinical practices and outcomes.
Source-backed journal facts
Topics in published research
Atrial Fibrillation Management and Outcomes; Acute Myocardial Infarction Research; Cardiovascular Function and Risk Factors; Cardiac Imaging and Diagnostics; Heart Failure Treatment and Management; Lipoproteins and Cardiovascular Health.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
JAMA Cardiology is a premier peer-reviewed medical journal that plays a critical role in advancing the field of cardiovascular medicine. As a member of the Journal of the American Medical Association (JAMA) family, it focuses on publishing high-impact research, clinical studies, and expert insights that shape the future of cardiovascular care. The scope of JAMA Cardiology is broad, addressing a wide range of cardiovascular diseases, treatment options, innovative technologies, and emerging trends in heart health. This article delves into the key areas that JAMA Cardiology covers and the significance of its contributions to the global cardiovascular community.
1. Cardiovascular Disease Research
One of the primary focuses of JAMA Cardiology is cardiovascular disease research. The journal publishes original articles that explore the pathophysiology, epidemiology, prevention, and management of various heart conditions. Topics range from coronary artery disease, heart failure, arrhythmias, valvular heart disease, and congenital heart conditions, to innovative areas like regenerative medicine and gene therapy. Through rigorous peer-reviewed research, JAMA Cardiology provides clinicians and researchers with critical insights that guide treatment protocols, improve patient outcomes, and contribute to the development of new therapies.
2. Clinical Trials and Treatment Advancements
JAMA Cardiology plays a vital role in disseminating findings from landmark clinical trials. By publishing detailed results and analyses, the journal aids clinicians in understanding the latest advancements in pharmacological and interventional treatments for cardiovascular conditions. These trials often set the standard for clinical practice and can lead to the approval of new medications, surgical techniques, or device-based therapies. Whether it's new anticoagulants, lipid-lowering therapies, or innovative stents, JAMA Cardiology highlights the breakthroughs that redefine cardiovascular care.
3. Preventive Cardiology and Public Health
Prevention is a cornerstone of cardiovascular medicine, and JAMA Cardiology dedicates significant attention to research focused on the prevention of heart disease. From lifestyle modifications to pharmacological interventions, the journal publishes studies that evaluate effective strategies for reducing cardiovascular risk. Public health initiatives aimed at addressing widespread risk factors such as hypertension, obesity, and diabetes are frequently featured. By fostering a better understanding of prevention, JAMA Cardiology supports efforts to reduce the global burden of heart disease and promote healthier communities.
4. Cardiac Imaging and Technological Innovations
The scope of JAMA Cardiology extends to the evolving field of cardiac imaging and the integration of advanced technologies in cardiovascular practice. The journal explores innovations in imaging techniques, including echocardiography, MRI, CT, and nuclear cardiology. These technologies not only enhance diagnostic accuracy but also provide critical information for treatment planning and monitoring disease progression. Additionally, JAMA Cardiology covers emerging digital health tools, artificial intelligence (AI), and telemedicine, all of which are shaping the future of cardiology.
5. Expert Opinions and Reviews
In addition to original research, JAMA Cardiology provides a platform for expert opinions, reviews, and meta-analyses. These articles synthesize the latest evidence, offering valuable perspectives on the management of complex cardiovascular conditions. Clinical guidelines and consensus statements, often developed by leading cardiologists, are also published in the journal, ensuring that healthcare providers are equipped with up-to-date recommendations to deliver the best care for their patients.
6. Educational Resources and Continuing Medical Education (CME)
JAMA Cardiology offers valuable educational resources for clinicians seeking to expand their knowledge of cardiovascular medicine. It provides Continuing Medical Education (CME) opportunities to support lifelong learning for healthcare professionals. These educational offerings ensure that clinicians stay abreast of the latest research findings, treatment protocols, and technological advancements, ultimately enhancing patient care.
Recent Research Articles
Latest publications matched automatically by ISSN.
Advanced Subclinical Atherosclerosis in Young Individuals and Risk of Mortality Over 30 Years
Sungwoo Choi, Omar Dzaye, Zeina Dardari, Zhiqi Yao et al.
2026-10-23 · DOI: 10.1001/jamacardio.2026.4819McConnell Sign After Syncope in a Man in His 60s
Robin A. P. Weir, Andrea Perrie
2026-10-21 · DOI: 10.1001/jamacardio.2026.3620E-Cigarettes—Lessons From History and Implications for Public Health
Andrew L. Pipe
2026-10-21 · DOI: 10.1001/jamacardio.2026.4732Dietary Strategies for the Prevention of Cardiovascular Disease
Sarah Lewington, Robert Clarke
2026-10-21 · DOI: 10.1001/jamacardio.2026.4565Tricuspid Regurgitation in Transthyretin Amyloid Cardiomyopathy
Amolakhji Rajput, Tasbeeha Akram
2026-10-21 · DOI: 10.1001/jamacardio.2026.4493Vascular Function and Cardiorespiratory Fitness in Adults Who Use Nicotine Vapes
Maxime Boidin, Hans Degens, Rehan T. Junejo, Robyn Meharg et al.
2026-10-21 · DOI: 10.1001/jamacardio.2026.4626Tricuspid Regurgitation in Transthyretin Amyloid Cardiomyopathy—Reply
Laurenz Hauptmann, Christian Nitsche
2026-10-21 · DOI: 10.1001/jamacardio.2026.4496Periorbital Purpura and Fatigue in a Man Aged 57 Years
Mehmet Rasih Sonsöz, Duygu Inan, Istemi Serin
2026-10-14 · DOI: 10.1001/jamacardio.2026.3614A Proactive Digital Valve Care Pathway for Management of Severe Aortic Stenosis
Seyed Mohammad Forouzannia, Jassmine Hempstead, Katherine Steineman, Rong Duan et al.
2026-10-14 · DOI: 10.1001/jamacardio.2026.4394The Need for Cardiology News Coverage
Shelley Wood
2026-10-07 · DOI: 10.1001/jamacardio.2026.3978Prevalence of Unrecognized and Recognized Myocardial Infarction in the Rotterdam Study
Julie Anne Eni van Oortmerssen, Shuyue Yang, Ali Farzaneh, Eric Boersma et al.
2026-10-07 · DOI: 10.1001/jamacardio.2026.4233A Discordant Result of Discordance Analysis—Reply
Martin Mortensen, Børge Grønne Nordestgaard
2026-10-07 · DOI: 10.1001/jamacardio.2026.3635Long-Term Perspective on the Landscape of Recognized and Unrecognized Myocardial Infarction
Stephan Windecker, Robert A. Harrington
2026-10-07 · DOI: 10.1001/jamacardio.2026.4238A Discordant Result of Discordance Analysis
Allan D. Sniderman
2026-10-07 · DOI: 10.1001/jamacardio.2026.3632Cement Embolism After Vertebroplasty
Pedro Mangas Palma, Ana Isabel Pinho, Marta Braga
2026-10-07 · DOI: 10.1001/jamacardio.2026.3970Intensive vs Standard Blood Pressure Lowering in People With and Without Chronic Kidney Disease
Fotini Iatridi, Alistair J. Roddick, Natalie Staplin, Zhaojing Che et al.
2026-10-07 · DOI: 10.1001/jamacardio.2026.4445Cardiac Decompensation and Skin Lesions in a Patient in His 40s
Michał Węgiel, Paweł Kuczia, Danuta Sorysz
2026-10-01 · DOI: 10.1001/jamacardio.2026.3106Bridging the Heart Failure Postdischarge Gap With Artificial Intelligence
Diana A. Gorog, Thomas F. Lüscher
2026-10-01 · DOI: 10.1001/jamacardio.2026.3029Error in Author Name
2026-10-01 · DOI: 10.1001/jamacardio.2026.4516Causal Endotype–Based Classification of Myocardial Infarction
Matteo Armillotta, Francesco Angeli, Damiano Fedele, Sara Amicone et al.
2026-10-01 · DOI: 10.1001/jamacardio.2026.3794Reviews
Community Reviews
Version History
October 10, 2026 at 11:22 pm
April 19, 2025